(Q33398646)

26 July 2017

title

Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields). (English)

1 reference

26 July 2017

1 reference

3

Vladimír Dbalý

1 reference

26 July 2017

Eilon D Kirson

1

1 reference

26 July 2017

Rosa S Schneiderman

2

1 reference

26 July 2017

Frantisek Tovarys

4

1 reference

26 July 2017

Josef Vymazal

5

1 reference

26 July 2017

Aviran Itzhaki

6

1 reference

26 July 2017

Daniel Mordechovich

7

1 reference

26 July 2017

Zoya Gurvich

8

1 reference

26 July 2017

Esther Shmueli

9

1 reference

26 July 2017

Dorit Goldsher

10

1 reference

26 July 2017

Yoram Wasserman

11

1 reference

26 July 2017

Yoram Palti

12

1 reference

26 July 2017

publication date

8 January 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

9

1 reference

26 July 2017

page(s)

1

1 reference

The analysis of survival data: the Kaplan-Meier method

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Disruption of cancer cell replication by alternating electric fields

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Chemotherapy and irradiation interaction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Use of chemo-radiotherapy in locally advanced non-small cell lung cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Electrochemotherapy: an emerging drug delivery method for the treatment of cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Influence of aldehyde dehydrogenase activity on the sensitivity of lymphocytes and other blood cells to oxazaphosphorines

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

A pilot study with very low-intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1756-6649-9-1

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1756-6649-9-1

Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2647898

Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19133110

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1756-6649-9-1

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference